Loading...
Loading...
Among the 4 tracked institutional investors we monitor, LIXT (LIXTE BIOTECHNOLOGY HLDGS IN) is held with a combined value of $807.08K across 241,897 shares. The largest holder is VANGUARD GROUP INC with a position worth $294.53K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$807.08K
Total Shares Held
241,897
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $294.53K | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $285.51K | 0.00% | -13.5% |
| 3 | CITADEL ADVISORS LLC | $173.63K | 0.00% | +301.3% |
| 4 | STATE STREET CORP | $53.41K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of LIXT with a position worth $294.53K, representing 0.00% of their portfolio. In total, 4 institutional investors hold LIXT with a combined value of $807.08K.
In the most recent quarter, 1 fund opened a new position in LIXT. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $807.08K worth of LIXT stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $294.53K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For LIXT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their LIXT positions.